Citations

Showing 10 of 107961 citations.

Are functional dyspepsia and gastroparesis really ‘interchangeable’ diseases?
Camilleri, Michael , Talley, Nicholas J. , Talley, Nicholas J.

Mayo Clinic

Gut | August 27, 2025 | Volume: 75 | Issue: 5 | Pages: 851-853

10.1136/gutjnl-2025-336192 | PMID 40866221 Get It

Inpatient and Outpatient Radiology Report Access After the 21st Century Cures Act
Tariq, Amara , Schmitz, John J. , Varner, Jacob, Metcalfe, Allie M., Pollock, Jordan Riley , Sharma, Umesh, Tan, Nelly

Mayo Clinic

JAMA Network Open | August 27, 2025 | Volume: 8 | Issue: 8 | Pages: e2528683

10.1001/jamanetworkopen.2025.28683 | PMID 40864472 Get It

This cohort study examines trends in patient access of radiology imaging results after implementation of the 21st Century Cures Act in different clinical settings.
Low Measles Seropositivity in Vaccinated Children
Jones, Sara Pace, Joseph, Iype, Powell, Alexandria J., Ovsyannikova, Inna G. , Warner, Nathaniel D. , Grill, Diane E. , Sasi, Remya Vasanthi, Ajithakumari, Archana Mohankumar, Prasad, Raji, Reveendran, Remya, Devakikutty, Jayalekshmi, Mohanakumari, Vishnu Vikraman, Poland, Gregory A., Pillai, M. Radhakrishna , Jacob, Joshy , Quach, Huy Quang , Kennedy, Richard B. , Jones, Sara P., Powell, Alexandria J., Johnson, John Bernet , Mohanakumari, Vishnu VikramanThampi, Poland, Gregory A.

Mayo Clinic

JAMA Network Open | August 27, 2025 | Volume: 8 | Issue: 8 | Pages: e2529409

10.1001/jamanetworkopen.2025.29409 | PMID 40864465 Get It

ImportanceIndia’s goal of measles elimination remains unmet, as evidenced by significant recent outbreaks.ObjectiveTo identify seroprevalence rates among vaccinated children and to examine demographic factors that influence antibody responses.Design, Setting, and ParticipantsThis cross-sectional study included a highly vaccinated cohort of Indian children from the states of Kerala and Tamil Nadu between 2018 and 2023. Eligible children had received at least 2 doses of measles-containing vaccines; their mothers were recruited from various community settings, including local nursery and secondary schools, residential associations, and hospitals.ExposureMeasles-specific antibodies were quantified in serum samples.Main Outcomes and MeasuresMeasles-specific immunoglobulin G (IgG) and neutralizing antibodies were quantified in both children and mothers. Measles-specific IgM was also measured in children.ResultsThe total cohort comprised 684 children (median age, 9 years [range, 4-18 years]; 348 male [50.1%]) and 544 mothers. All children received at least 2 doses of measles-containing vaccines; 435 children (63.6%) received a third dose, and 7 (1.0%) received a fourth dose. Among the children, 621 (90.8%) had positive measles-specific IgG, and 623 (91.5%) had protective neutralizing antibodies titers, with a strong correlation between measles-specific IgG and neutralizing antibodies (r = 0.73; P < .001). Female children exhibited significantly higher titers of both measles-specific IgG and neutralizing antibodies compared with male children. While IgG and neutralizing antibody titers remained stable over time and were not associated with the number of vaccine doses in children, neutralizing antibody titers increased with age in mothers, likely due to repeated viral exposure. Notably, in 20 families with at least 2 children, differential measles-specific IgM profiles were observed between siblings despite high IgG and neutralizing antibody titers, suggesting ongoing breakthrough infections.Conclusions and RelevanceIn this cross-sectional study, substantial measles immunity gaps were found despite high vaccine coverage with evidence of breakthrough infections, posing significant challenges to India’s measles elimination efforts. These results underscore the urgent need to strengthen India’s immunization program and investigate the mechanisms driving suboptimal responses to measles vaccination; without addressing these immune response deficiencies, achieving measles elimination through increased vaccine coverage alone may remain unattainable in India.
Prevalence of Hidradenitis Suppurativa
Hagan, Paa Gyasi, Botvid, Sofia , Hove, Lone Storgaard, Christensen, Robin , Group, GHiSA, Knecht-Gurwin, Klaudia , Zobiri, S., Serradj, A. , Noor, Towhida , Guillem, Philippe , Parvizi, Mohammad Mahdi , Vardar, Caner, Maharbi, Waleed H. A. Al, Huijstee, Johanna C. van , Aarts, Pim , Dewi, Shinta Trilaksmi , Indrastuti, Niken , Suryawati, Nyoman , Adji, Aryani , Akhyar, Gardenia , Nopriyati, Nopriyati, Reyes‐Baraona, Francisco, Matas, Carlos, Saeed, Haroon , Moodley, Ameshin , Binamer, Yousef , Kamil, Moonyza Akmal Ahmad , Jocic, Ivana , Mijušković, Željko, Mallawaarachchi, Kanchana , Gangani, Chathurika, Tusheva, Ivana , Boshkovski, Vesna Brishkoska , Hu, Danchen , Medianfar, Cecilia E. , Benhadou, Farida , Naik, Haley B. , Boer, Jurr , Bouazzi, Dorra , Nielsen, Sabrina Mai , Prens, Errol P. , Jemec, Gregor B. E. , Group, GHiSA, Szepietowski, Jacek C. , Anaba, Ehiaghe L. , Chehad, Ahmed Samaouel , Bhuiyan, Mohammed Saiful Islam , Saki, Nasrin , Alpsoy, Erkan , Kanni, Theodora , Giamarellos‐Bourboulis, Evangelos J. , Frew, John W. , Maharbi, Waleed AL, Febriana, Sri Awalia , Pangastuti, Miranti , Nopriyati, Nopriyati , Hazlianda, Cut Putri , Matas, Carlos, Saeed, Haroon, Geng, Songmei , Saunte, Ditte Marie Lindhardt , Chandran, Nisha Suyien , Zee, Hessel H. van der , Zouboulis, Christos C. , Villumsen, Bente , Alavi, Afsáneh , Ibekwe, Perpetua U. , Hamzavi, Iltefat H. , Ingram, John R , Garg, Amit

Mayo Clinic

JAMA Dermatology | August 27, 2025 | Volume: 161 | Issue: 10 | Pages: 1022

10.1001/jamadermatol.2025.2373 | PMID 40864454 Get It

Importance Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a substantial burden. Standardized global prevalence estimates and data on associated sociodemographic and risk factors are lacking. Objective To estimate the global prevalence of HS and study differences in prevalence by age, sex, geographical location, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), smoking status, gross domestic product (GDP), and Human Development Index (HDI). Data Sources and Study Selection Included studies were conducted using the standardized Global Hidradenitis Suppurativa Atlas methodology with finalized data collection before May 19, 2023. Studies were required to use a population-based sampling method and conduct clinical confirmation of HS diagnosis following a screening questionnaire. Data Extraction and Synthesis Data were independently extracted from relevant studies by 2 reviewers (D.B. and C.E.M.) using a standardized form. Extracted variables included geographic location, age, sex, BMI (median and BMI >30), smoking status, HS prevalence estimates (with 95% CIs), GDP, and HDI. A proportional meta-analysis using a random-effects model was conducted on the included studies. Main Outcomes and Measures The primary outcome was the point prevalence of HS, confirmed by clinical examination. Secondary outcomes included differences in HS prevalence by sex, age, BMI category, smoking status, and country-level socioeconomic indicators (GDP and HDI). All outcomes were prespecified before data analysis. Results The sample included 22 743 participants, identifying 247 patients with HS, across 25 studies in 23 countries spanning 6 continents. The median proportion of female patients with HS was 55.6%, and the median age was 34.5 years. While the prevalence estimates showed considerable inconsistency ( I 2 > 75%; τ 2 = 0.747), the overall random-effects global prevalence of HS was 0.99% (95% CI, 0.67%-1.46%). Female sex was the only factor observed to be associated with the prevalence estimates (β = 1.02; 95% CI, 1.01-1.03). Conclusions and Relevance In this meta-analysis, an estimated global prevalence of HS between 0.67% and 1.46% surpassed previous global estimates. Substantial global variations in HS prevalence were also observed. Female sex was the only factor associated with prevalence in this sample. Future studies assessing genetic, environmental, and etiological factors are warranted to explain the heterogeneity in prevalence.
Advancing Early Detection of Chronic Obstructive Pulmonary Disease Using Generative AI
Hathaway, Quincy A. , Singh, Yashbir , Singh, Yashbir , Hathaway, Quincy A

Mayo Clinic

Radiology: Artificial Intelligence | August 27, 2025 | Volume: 7 | Issue: 5 | Pages: No page available

10.1148/ryai.250555 | PMID 40862689 Get It

Focus on Immune Aging
Weyand, Cornelia M. , Merad, Miriam, Dixit, Vishwa Deep, Weyand, Cornelia , Merad, Miriam, Dixit, Vishwa Deep

Mayo Clinic

No container title available | August 27, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.52843/cassyni.nszqy9 Get It

The reshaping of the immune system which occurs during aging has detrimental consequences for tissue function and pathology. The August 2025 issue of Nature Aging provides a Focus on immune aging, featuring a series of reviews and opinion pieces on recent advances in immune aging research. This panel discussion hosted by Nature Aging with experts in the field accompanies the Focus issue, and covers emerging concepts in immune aging as well as translational therapies.
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Mahadevan, Uma , Seow, Cynthia H. , Flanagan, Emma , Julsgaard, Mette , Kane, Sunanda V. , Watermeyer, Gillian , Fisher, Susan, Anderson, Phil, Ďuricová, Dana , Dubinsky, Marla C. , Long, Millie, IBD, the Global Consensus Group for Pregnancy and, Huang, Vivian , Julsgaard, Mette , Barnes, Edward L. , Chaparro, María , Friedman, Sonia , Ng, Siew C. , Torres, Joana , Yamamoto-Furusho, Jesus , Robinson, Christopher James , Gearry, Richard B. , IBD, the Global Consensus Group for Pregnancy and

Mayo Clinic

American Journal of Gastroenterology | August 27, 2025 | Volume: 121 | Issue: 1 | Pages: 31-79

10.14309/ajg.0000000000003651 | PMID 40862489 Get It

Introduction: Pregnancy can be a complex and risk filled event for women with inflammatory bowel disease (IBD). High-quality studies in this population are lacking, with limited data on medications approved to treat IBD during pregnancy. For patients, limited knowledge surrounding pregnancy impacts pregnancy rates, medication adherence, and outcomes. Limited provider knowledge leads to highly varied practices in care affected by local dogma, available resources, individual interpretation of the literature, and fear of harming the fetus. The variations in guidelines by different societies and countries reflect this and lead to confusion for physicians and patients alike. The Global Consensus Consortium is a group of 39 IBD and content experts and 7 patient advocates from 6 continents who convened to review and assess current data and come to an agreement on best practices based on these data. Methods: The GRADE process was used when sufficient published data were available and the RAND process in those instances where expert opinion was needed to guide consistent practice. Recommendations were informed by the guiding principle that maternal health best supports infant health. Results: The topics were divided into 10 categories with 34 GRADE recommendations and 35 Consensus statements. Discussion: Overall, the goal of the group was to provide data-driven and practical guidance to improve the care of women with IBD around the globe based on the best available research.
Bridging language gaps in healthcare: a systematic review of the practical implementation of neural machine translation technologies in clinical settings
Karakuş, İbrahim Serhat , Strechen, Inna , Gupta, Ankita , Nalaie, Keivan , Chen, Christine L, Barwise, Amelia , Chen, Christine , Barwise, Amelia K , Chen, Christine L , Chen, Christine L, Hassett, Leslie C.

Mayo Clinic

Journal of the American Medical Informatics Association | August 27, 2025 | Volume: 32 | Issue: 11 | Pages: 1756-1766

10.1093/jamia/ocaf150 | PMID 40966445 Get It

Abstract Objectives Effective communication is crucial in healthcare, and for patients with a non-English language preference (NELP), professional interpreters are recognized as the gold standard in supporting bidirectional communication. However, interpreters are not always readily available, prompting the exploration of other options for translation and interpretation. The recent developments in artificial intelligence-based neural network translation tools, namely neural machine translation (NMT) may enable robust interpretation and translation. Materials and Methods We conducted a systematic review (SR) to evaluate the literature on NMT for this purpose. We did a comprehensive search of several databases with guidance from a professional librarian. The search was limited to the year 2000 onwards and English language. Title and abstract screening and full-text review were independently conducted by two reviewers with conflicts resolved by a third reviewer Results 2867 studies were identified with 10 studies included in the final analysis. Among these, six evaluated interpretation in real or simulated clinical settings and four examined translation of discharge materials. Google Translate and ChatGPT were assessed in several studies. Accuracy differed by language, with low-resource languages performing worse. Discussion NMT technologies in healthcare have several advantages including broad language accessibility and potential cost savings for institutions. Despite improved accuracy of these novel tools, due to possible critical errors NMT tools are not yet ready for widespread clinical use. Conclusion Future studies should focus on optimizing evaluation methods as well as how best to integrate these technologies into real-time clinical settings.